Skip to main navigation Skip to search Skip to main content

Lymphatic mapping with tracer administration into the primary breast cancer

  • O. E. Nieweg*
  • , S. H. Estourgie
  • , R. A. Valdés Olmos
  • , E. J. T. Rutgers
  • , C. A. Hoefnagel
  • , B. B. R. Kroon
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

There is an ongoing debate over the best tracer injection technique in lymphatic mapping for breast cancer. The technique of low tracer volume administration into the primary breast cancer is presented. The reasons that led to this approach are explained as well as its advantages. Excision of radioactivity that remains at the injection site in the breast cancer prevents the gamma ray scatter that may hamper retrieval of a sentinel node. The intralesional injection technique avoids potential injection of tracer fluid across a lymphatic watershed, it enables identification of extra-axillary sentinel nodes and allows probe-guided excision of non-palpable tumours. © 2002 Elsevier Science Ltd. All rights reserved.
Original languageEnglish
Pages (from-to)95-97
JournalEuropean journal of surgical oncology
Volume29
Issue number1
DOIs
Publication statusPublished - 2003
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Lymphatic mapping with tracer administration into the primary breast cancer'. Together they form a unique fingerprint.

Cite this